Some people respond very well to semaglutide, while others may not experience the same degree of appetite suppression or weight change
When used off-label for weight loss, Ozempic works by mimicking glucagon-like peptide-1, a hormone that regulates blood sugar and satiety
Weight loss can improve insulin sensitivity, reduce cardiovascular risk factors such as blood pressure and lipid levels, and enhance overall quality of life
The disorder runs the spectrum from subclinical hyperthyroidism to thyrotoxicosis, a life-threatening event
Early research suggests a possible connection between GLP-1 drugs and epilepsy risk A preliminary study involving people with diabetes has found a possible link between the use of glucose-lowering GLP-1 drugs and a reduced chance of developing epilepsy
These studies may involve areas such as receptor activity, metabolic signaling, appetite regulation mechanisms, gastric emptying research, and glucose pathway studies